Ashwagandha 20000 mg - Gélules végétales
Food supplement declared in France, decision dated 14 May 2026
Ashwagandha 20000 mg - Gélules végétales (Compagnie des Sens) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 120 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Compagnie des Sens
- Food business operator placing the product on the market
- LA COMPAGNIE DES SENS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 4 gélules (1828 mg)
- Directions for use
- 4 gélules par jour, avec un grand verre d’eau.
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Autre : Stress - Fatigue, Femmes enceintes, Problèmes cardiaques, Problèmes de foie, Sous antidépresseurs
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : Stress - Fatigue
Declaration 353021, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Withania somnifera (L.) Dunal | Root | Dry hydroalcoholic extract | 120 mg |
Other ingredients
huile de tournesol, amidon de riz, Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes, et en cas de troubles cardiaque, endocrinien ou hépatique. Éviter la prise lors de l'utilisation de véhicules/machines ou en association avec des substances dépresseurs du système nerveux central. Ne se substitue pas à une alimentation variée et équilibrée et un mode de vie sain. Tenir hors de portée des enfants. Conserver à l'abri de la lumière, l'humidité et la chaleur.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Compagnie des Sens
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ashwagandha 20000 mg - Gélules végétales (Compagnie des Sens): composition and regulation”, https://compoatlas.com/en/supplements/products/353021-ashwagandha-20000-mg-gelules-vegetales, updated 15 November 2026.